2 results
Approved WMOPending
To assess the effectivity and safety of 1.0 molar gadobutrol (Gadovist®) for breast MRI
Approved WMOWill not start
The aim of the study is twofold. The first is the impact of DRL-21994 and the registered product on the release of vessels studied and compared. The second is the speed with which DRL-21994 is included in the body examined, as well as the degree of…